Effect of Progesterone Levels on 15th Day After Embryo Transfer in Early Miscarriage < 7 WG or Evolving Pregancy Rates

September 29, 2021 updated by: University Hospital, Montpellier

Progesterone level has been studied at days before embryo transfert. But, progesterone blood level has not been studied 15 days after embryo transfert. The aim of this study is to study progesterone level impact at 15 days after embryo transfert on evolving pregnanies or early miscarriages.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

540

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Noémie RANISAVLJEVIC, M.D., Ph.D
Phone Number: 33 06 37 10 89 38
Email: n-ranisavljevic@chu-montpellier.fr

Study Contact Backup

Name: MARIE DUPORT PERCIER, assistante
Phone Number: 33 0467336427
Email: m-duportpercier@chu-montpellier.fr

Study Locations

France
- - Montpellier, France, 34295
    - Recruiting
    - Uhmontpellier
    - Contact:
      
      Noémie RANISAVLJEVIC, M.D., Ph.D
      
      Phone Number: 33 06 37 10 89 38
      
      Email: n-ranisavljevic@chu-montpellier.fr
    - Contact:
      
      MARIE DUPORT PERCIER
      
      Email: m-duportpercier@chu-montpellier.fr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 43 years (Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

ART program in Montpellier hospital >18 years old Blood progesterone level 15 days after embryo transfert Pregnancy development know

Description

Inclusion criteria:

ART program in Montpellier hospital
age >18 years old
Blood progesterone level 15 days after embryo transfert
Pregnancy development know

Exclusion criteria:

- non uterine pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of blood progesterone Time Frame: 1 day	blood progesterone at day 15 after embryo transfert	1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Montpellier

Investigators

Study Director: Noémie Ranisavljevic, M.D., Ph.D, University Hospital, Montpellier
Principal Investigator: MARIE DUPORT PERCIER, University Hospital, Montpellier

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

September 1, 2021

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

September 18, 2021

First Submitted That Met QC Criteria

September 29, 2021

First Posted (Actual)

October 12, 2021

Study Record Updates

Last Update Posted (Actual)